Variants in RYR1 are implicated in malignant hyperthermia (MH), a rare hypermetabolic disorder characterized by constitutive activation of the RYR1 channel in response to a subset of anesthetic medications, producing prolonged skeletal muscle contraction [16,18,19,20,21,22]. This evidence concerns the gene RYR1 and Malignant hyperthermia.